FDA Approves New Uses for Existing Cancer Treatments
November 22, 2014 – Staff Reports
Comments From Readers
November 21, 2014
A Focus on a Cure for Non-Hodgkin Lymphoma
November 22, 2014 – Debu Tripathy, MD
FDA Aims to Start Regulating Custom Diagnostic Tests
November 24, 2014 – Susan Kreimer
Managing Thrombocytopenia
November 24, 2014 – Lacey Marlow
Currently Viewing
NORD Offers Information and Support for Patients of Rare Cancers
November 24, 2014 – Peter L. Saltonstall
Guy's Guide
November 24, 2014 – Michael Irving
Rare Finds: A Rare Cancer Diagnosis
November 24, 2014 – Charlotte Huff
Recovering from Brain Cancer Surgery Takes Time
November 24, 2014 – Jennifer L. W. Fink, RN
Helping Children Heal
November 24, 2014 – Maureen Salamon
Bad Behavior
November 24, 2014 – Jeannette Moninger
The Fitness Factor
November 24, 2014 – Laura Beil
B-Cell Lymphomas: A Long and Winding Road
November 25, 2014 – Heather L. Van Epps, PhD
Surviving Caregiving
November 25, 2014 – Kathy LaTour
Few Aware that Dense Breasts Increase Cancer Risk
December 01, 2014 – Beth Fand Incollingo
Cancer Center Fundraiser was de la Renta's Farewell
December 01, 2014 – Elizabeth Whittington
Sunshine Act Sheds Light on Gifts to Doctors From Pharmaceutical Companies
December 01, 2014 – Lena Huang
Harmony Hill Retreat Center
December 01, 2014 – Elizabeth Whittington
Yoga's Benefits Explored
December 01, 2014 – Kathy LaTour
Adult Female Survivors at Risk for Sexual Issues
December 01, 2014 – Katherine Lagomarsino
TheAnswertoCancer.org
December 01, 2014 – Elizabeth Whittington
Primary Care After Cancer Treatment
December 01, 2014 – Len Lichtenfeld, MD
A Breast Cancer Alphabet
December 01, 2014 – Katherine Lagomarsino
Updates from the European Society for Medical Oncology
December 01, 2014 – Staff Reports
CURE Magazine and curetoday.com Are Under New Management
December 01, 2014 – Mike Hennessy

NORD Offers Information and Support for Patients of Rare Cancers

NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.
BY Peter L. Saltonstall
PUBLISHED November 24, 2014
Through my work with the National Organization for Rare Disorders (NORD), an advocacy and support services group for patients with rare diseases, I meet patients virtually every day. Their stories all have some common elements: the length of time it takes to get an accurate diagnosis, the difficulty in finding reliable information about their disease and the appreciation for meeting and communicating with other patients who share the same experiences. The rare-disease journey is a challenging one for patients and their families and loved ones, but accurate information and contact with knowledgeable people can ease the way a bit.

NORD was founded in 1983 by parents of children with rare diseases. Over the past three decades, the organization has been a powerful advocacy voice for patients, with great success in elevating public understanding of rare diseases and advancing public policies to address the very special needs of patients with rare diseases. At the same time, NORD has developed programs and resources to help patients obtain reliable information about their diseases, and to communicate with others sharing the same journey.

It is essential that patients facing a rare cancer educate themselves. Reliable information is key to obtaining the best care. General Internet searches for rare cancers, however, can result in information that is difficult to understand and sometimes misleading or just plain wrong. Some websites are designed to sell products. It is important to select websites that are known to provide reliable information. This is true in all cases, but especially for health-related websites, because there are so many of them, and the consequences of relying on inaccurate information can be significant.

NORD provides information in non-technical language about some rare cancers in its Rare Disease Database. In addition, some of NORD’s member organizations focus on specific rare cancers and issue reliable information oriented toward the patient. Visit rarediseases.org for more information.

Other good resources for people with newly diagnosed cancer can be found at the American Society of Clinical Oncology’s patient information website (cancer.net), Cancer Research UK (cancerresearchuk. org), the National Cancer Institute (cancer.gov), the Association of Cancer Online Resources (acor.org) and PubMed (ncbi.nlm.nih.gov/pubmed).

Patients facing a rare cancer should try to gather as many relevant articles as they can find, taking note of medical experts and centers that treat their specific condition. Primary care physicians can often help patients contact these medical experts.

Other patients can provide support and help those with newly diagnosed disease feel less isolated. There are a number of ways that patients can connect online with others who have the same or a similar diagnosis. Good points of contact for online connections with patients who have rare cancers include the Rarer Cancers Foundation (rarercancers.org) and the Rare Cancer Alliance (rare-cancer.org).

Looking to the future, it is clear that we must sustain and build on the progress already made. Every day, we are learning more and more about rare diseases generally and rare cancers specifically. Medical progress during our lifetimes has been remarkable. Now we need to capture that new information and translate it into better diagnostic techniques and better treatments. And we need to increase the ability of our health care professionals to diagnose rare diseases more quickly, so that treatment can be initiated earlier in the disease progression.

—Peter L. Saltonstall is NORD’s president and chief executive officer.

Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Anal Cancer CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In